Because of the small number of severe cases of COVID-19 disease, statistical significance for efficacy in preventing severe COVID-19 disease could not be determined, but there was a clear trend in favor of BNT162b2 (66.4%, 95% CI −124.8 to 96.3).
← all excerpts
Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
1
—
—